(Q85044101)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compounds (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Owen M Peters

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

S O Bachurin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

T A Shelkovnikova

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

V L Buchman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

N N Ninkina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

Doklady. Biochemistry and biophysics

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

428

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

235-238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20848907%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1134/s1607672909050032

14 February 2020

exact match

0 references

cites work

Action of dimebon on histamine receptors

1 reference

12 December 2020

Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies

1 reference

12 December 2020

Neurons Expressing the Highest Levels of γ-Synuclein Are Unaffected by Targeted Inactivation of the Gene

1 reference

12 December 2020

Cell systems and the toxic mechanism(s) of alpha-synuclein

1 reference

12 December 2020

A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.

1 reference

12 December 2020

Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer

1 reference

12 December 2020

Emerging prospects for the disease-modifying treatment of Alzheimer's disease

1 reference

12 December 2020

Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice

1 reference

12 December 2020

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease

1 reference

12 December 2020